Financing, Equity Capital Markets

Praxis Precision Medicines

01/24
|
$172.4 Million
Praxis
Piper Sandler served as bookrunner for Praxis Precision Medicines, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sub-Sector
Biopharma